Target intelligence / Profile preview

RNA, U6 small nuclear 1339, pseudogene (RNU6-1339P)

Target: RNU6-1339P
Molecular classification: Other (Pseudogene, Small nuclear RNA pseudogene)

Overview

RNU6-1339P is a processed pseudogene derived from U6 small nuclear RNA, a key component of spliceosomal snRNP complexes involved in pre-mRNA splicing[1][2][3][5][6]. Unlike functional U6 snRNA, pseudogene copies such as RNU6-1339P do not produce functional RNA or protein products and are generally considered non-functional remnants within the genome. U6 snRNA pseudogenes arise primarily through L1 retrotransposition mechanisms, resulting in truncated and nonfunctional copies dispersed throughout the genome[2]. Although most pseudogenes, including RNU6-1339P, do not serve as direct therapeutic targets, some pseudogenes are increasingly being studied for regulatory roles in gene expression via miRNA decoy or epigenetic modulation, but such activity has not been reported for RNU6-1339P[8]. No associated drugs, biomarkers, or safety concerns are established for this gene.

Other names: RNU6-1339PRNA, U6 small nuclear 1339, pseudogene

Biological functions

None known (Pseudogenes, including snRNA pseudogenes, are generally thought to lack canonical biological functions but may affect gene regulation in some contexts)

Disease associations

Other (Pseudogenes as a class may be involved in disease via competing endogenous RNA mechanisms or epigenetic regulation, but no disease associations are specifically reported for RNU6-1339P)

Beyond the preview

Go deeper on RNA, U6 small nuclear 1339, pseudogene (RNU6-1339P).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Explore the programs pursuing this target and their development progress.

Drug candidates
Developers
Development stage

Clinical trials

Follow the clinical studies evaluating therapies directed at this target.

Trial design
Status
Readouts

Competitive landscape

Compare approaches across drug candidates, modalities, and indications.

Programs
Modalities
Indications

Literature & evidence

Investigate the research and source evidence behind target biology and development.

Publications
Sources
Analysis

Patents

Explore patent activity around therapies and technologies addressing this target.

Patents
Assignees
Technologies

Research & analysis

Connect target biology, drug development, and emerging evidence in your research.

Biology
Development news
Analysis

Bring the full picture into focus.

See how Gosset can support your research on RNA, U6 small nuclear 1339, pseudogene (RNU6-1339P).

Explore the full profile